Indraprastha Medical Corporation Ltd vs Vimta Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Indraprastha Medical Corporation Ltd is ₹ 299.95 as of 23 Oct 15:30 . The P/E Ratio of Indraprastha Medical Corporation Ltd changed from 0 on March 2021 to 0 on March 2024 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Vimta Labs Ltd changed from 16.6 on March 2021 to 24 on March 2024 . This represents a CAGR of 9.65% over 4 years The Market Cap of Indraprastha Medical Corporation Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Vimta Labs Ltd changed from ₹ 355.7 crore on March 2021 to ₹ 985.7 crore on March 2024 . This represents a CAGR of 29.02% over 4 years The Revenue of Indraprastha Medical Corporation Ltd is ₹ 0 crore as of Jun '24 .The Revenue of Vimta Labs Ltd is ₹ 75.57 crore as of Jun '24 . The EBITDA of Indraprastha Medical Corporation Ltd is ₹ 0 crore as of Jun '24 .The EBITDA of Vimta Labs Ltd is ₹ 25 crore as of Jun '24 . The Net Profit of Indraprastha Medical Corporation Ltd is ₹ 0 crore as of Jun '24 .The Net Profit of Vimta Labs Ltd is ₹ 12.28 crore as of Jun '24 . The Dividend Payout of Indraprastha Medical Corporation Ltd changed from 39.1 % on March 2022 to 19.97 % on March 2026 . This represents a CAGR of -12.57% over 5 yearsThe Dividend Payout of Vimta Labs Ltd changed from 20.79 % on March 2021 to 11.52 % on March 2026 . This represents a CAGR of -9.37% over 6 years .

About Indraprastha Medical Corporation Ltd

Indraprastha Medical Corporation Limited was incorporated on 16th March, 1988.
The main business of the Company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis.
The Company was formed as a joint venture between the Government of Delhi and the Apollo Hospitals Group to establish the Indraprastha Apollo Hospitals. The Hospital provides international standard medical care, offering a wide range of multi-specialty services.
Key specialties with strong growth and revenue potential include transplants, cardiology, oncology, neurology, and orthopaedics. The company came out with the public issue of 2,29,18,300 equity shares of Rs 10 each for cash at par aggregating Rs 22,91,83,000.
IMCL is setting up a multi-disciplinary super speciality teritary care referral hospital at New Delhi.

About Vimta Labs Ltd

Vimta Labs Limited., established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries.
Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas like preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products.

FAQs for the comparison of Indraprastha Medical Corporation Ltd and Vimta Labs Ltd

Which company has a larger market capitalization, Indraprastha Medical Corporation Ltd or Vimta Labs Ltd?

Market cap of Indraprastha Medical Corporation Ltd is 2,749 Cr while Market cap of Vimta Labs Ltd is 2,096 Cr

What are the key factors driving the stock performance of Indraprastha Medical Corporation Ltd and Vimta Labs Ltd?

The stock performance of Indraprastha Medical Corporation Ltd and Vimta Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indraprastha Medical Corporation Ltd and Vimta Labs Ltd?

As of October 25, 2026, the Indraprastha Medical Corporation Ltd stock price is INR ₹299.95. On the other hand, Vimta Labs Ltd stock price is INR ₹468.95.

How do dividend payouts of Indraprastha Medical Corporation Ltd and Vimta Labs Ltd compare?

To compare the dividend payouts of Indraprastha Medical Corporation Ltd and Vimta Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.